EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down - Here's Why

Key Points

• EssilorLuxottica shares gapped down pre-market, opening at $108.3850 after a $115.28 close and last trading around $109.01 on light volume (~3,523 shares).
• Analysts have been upgrading the stock—HSBC and Kepler raised their ratings to Buy—and MarketBeat shows a consensus Buy (2 Strong Buy, 5 Buy, 1 Hold).
• The stock is trading well below its 50‑day ($122.72) and 200‑day ($152.12) moving averages; the company has low leverage (debt-to-equity 0.17) but modest liquidity (current ratio 0.99, quick ratio 0.70).

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $115.28, but opened at $108.3850. EssilorLuxottica shares last traded at $109.01, with a volume of 3,523 shares traded.

Analysts Set New Price Targets

ESLOY has been the topic of a number of recent analyst reports. HSBC raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Wednesday, January 14th. Kepler Capital Markets raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Thursday, January 15th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy".

EssilorLuxottica Stock Performance

The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70. The stock's 50-day moving average is $122.72 and its two-hundred day moving average is $152.12.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.